APGE
Apogee Therapeutics Inc
NASDAQ · Biotechnology
$62.24
+0.11 (+0.18%)
Analyst Consensus
Strong Buy
20 analysts
Price Target
Analyst Price Target
+63.2% upside
Low Target
$78.76
Average Target
$101.57
High Target
$153.22
Current Price
$62.24
Current
$62.24
$62.24
Target
$101.57
$101.57
$78.76
$101.57 avg
$153.22